# Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes

> **NCT05508061** · NA · COMPLETED · sponsor: **Inreda Diabetic B.V.** · enrollment: 12 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Insulin Lispro Cartridge [Lyumjev]
- **DRUG:** Insulin Lispro Cartridge

## Key facts

- **NCT ID:** NCT05508061
- **Lead sponsor:** Inreda Diabetic B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-19
- **Primary completion:** 2023-03-16
- **Final completion:** 2023-03-16
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05508061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05508061, "Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05508061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*